ATE136903T1 - Impfstoff, der zecken-antigene enthält - Google Patents

Impfstoff, der zecken-antigene enthält

Info

Publication number
ATE136903T1
ATE136903T1 AT87907920T AT87907920T ATE136903T1 AT E136903 T1 ATE136903 T1 AT E136903T1 AT 87907920 T AT87907920 T AT 87907920T AT 87907920 T AT87907920 T AT 87907920T AT E136903 T1 ATE136903 T1 AT E136903T1
Authority
AT
Austria
Prior art keywords
vaccine containing
tick antigens
containing tick
antigens
vaccine
Prior art date
Application number
AT87907920T
Other languages
English (en)
Inventor
Gary Stewart Cobon
Joanna Terry Moore
Law Anthony York Johnston
Peter Willadsen
David Harold Kemp
Alagacone Sriskantha
George Alfred Riding
Keith Norman Rand
Original Assignee
Biotech Australia Pty Ltd
Commw Scient Ind Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd, Commw Scient Ind Res Org filed Critical Biotech Australia Pty Ltd
Application granted granted Critical
Publication of ATE136903T1 publication Critical patent/ATE136903T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Insects & Arthropods (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT87907920T 1986-11-27 1987-11-27 Impfstoff, der zecken-antigene enthält ATE136903T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPH919686 1986-11-27
AUPI257087 1987-06-19
AUPI491287 1987-10-16

Publications (1)

Publication Number Publication Date
ATE136903T1 true ATE136903T1 (de) 1996-05-15

Family

ID=27157333

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87907920T ATE136903T1 (de) 1986-11-27 1987-11-27 Impfstoff, der zecken-antigene enthält

Country Status (12)

Country Link
EP (1) EP0290565B1 (de)
JP (1) JP2811190B2 (de)
AR (1) AR248046A1 (de)
AT (1) ATE136903T1 (de)
BR (1) BR8707549A (de)
DE (1) DE3751777T2 (de)
IL (1) IL84574A (de)
IN (1) IN165830B (de)
MY (1) MY101874A (de)
NZ (1) NZ222717A (de)
WO (1) WO1988003929A1 (de)
ZW (1) ZW22487A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225295A (en) 1987-07-07 1991-07-26 Biotech Australia Pty Ltd Nematode antigen, its production and vaccines containing it
US5344645A (en) * 1991-03-22 1994-09-06 Center For Innovation And Business Development Foundation Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived therefrom
US5418137A (en) * 1991-09-26 1995-05-23 Paravax, Inc. Flea membrane binding site proteins as screening tools
WO1994006463A1 (en) * 1992-09-14 1994-03-31 Pfizer Inc Immortalized cells and uses therefor
BR0110278A (pt) 2000-04-25 2003-01-07 Evolutec Ltd Composição de vacina, anticorpo ou anti-soro, métodos de produção de um anticorpo ou de um anti-soro e de imunização de um animal contra um ectoparasita que se alimenta de sangue, proteìna de cemento de carrapato, e, uso de uma proteìna de cemento de carrapato
WO2011031139A1 (en) * 2009-09-09 2011-03-17 Universiteit Utrecht Holding B.V. An ataq protein or a part thereof as a vaccine
GB201112587D0 (en) * 2011-07-22 2011-09-07 Moredun Res Inst Vaccine
US9579369B2 (en) 2013-03-29 2017-02-28 Intervet Inc. Vaccine against Rhipicephalus ticks
BR102013026625B1 (pt) * 2013-10-16 2022-04-26 Universidade Federal de Viçosa Vacina de peptídeos recombinantes para o controle de carrapatos e sequências de nucleotídeos codificadoras dos peptídeos recombinantes
WO2018141029A1 (en) 2017-02-06 2018-08-09 Meat & Livestock Australia Limited Immunostimulating compositions and uses therefore

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569252B2 (en) * 1982-07-12 1988-01-28 Commonwealth Scientific And Industrial Research Organisation Tick paralysis vaccines and toxins
GB2142334B (en) * 1983-03-14 1986-08-28 Int Centre Of Insect Physiolog Immunogenic preparations
AU598445B2 (en) * 1984-08-08 1990-06-28 Commonwealth Scientific And Industrial Research Organisation Antigenic extracts derived from boophilus microplus
AU592997B2 (en) * 1985-07-03 1990-02-01 Pitman-Moore Australia Limited Tick vaccine

Also Published As

Publication number Publication date
DE3751777T2 (de) 1997-01-09
EP0290565A1 (de) 1988-11-17
JPH01502115A (ja) 1989-07-27
WO1988003929A1 (en) 1988-06-02
ZW22487A1 (en) 1989-06-21
DE3751777D1 (de) 1996-05-23
JP2811190B2 (ja) 1998-10-15
IN165830B (de) 1990-01-20
IL84574A (en) 1994-10-07
MY101874A (en) 1992-01-31
AR248046A1 (es) 1995-05-31
EP0290565B1 (de) 1996-04-17
NZ222717A (de) 1991-07-26
EP0290565A4 (de) 1990-03-12
BR8707549A (pt) 1989-02-21

Similar Documents

Publication Publication Date Title
DE3752263D1 (de) Impfstoffe
NO873080D0 (no) Mikrobicid tilberedning.
DK10087A (da) Praeparat
ATE136903T1 (de) Impfstoff, der zecken-antigene enthält
KR890700356A (ko) 신규의 백신
DK244488D0 (da) Efterskummende praeparat
DE3786301D1 (de) Kombinierter impfstoff.
DK255787D0 (da) Praeparat
DK282384A (da) Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet
NO871759D0 (no) Fremgangsmaate for fremstilling av sucralfat-preparater.
DK574187D0 (da) Analgetiske praeparater
DE3782960D1 (de) Impfstoffe.
DK375488D0 (da) Vaccine
DK8188D0 (da) Veterinaert praeparat
DK653887A (da) Kapsel
OA08478A (fr) Vaccin contre la mélanome.
DK503386D0 (da) Peptidpraeparater
DK286087D0 (da) Vaccinefremstilling
DK30788A (da) Co-vaccinationspraeparat
KR870011824U (ko) 넥타이
KR880003944U (ko) 넥타이
KR870014200U (ko) 차 양 모
KR870017760U (ko) 모자안테
ATE83154T1 (de) Impfstoffe.
DK653388D0 (da) Vaccine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties